Aller au contenu principal
Profil bibliographique

X Li

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

4Publications signalées
220Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Diabetes Treatment and ManagementChronic Kidney Disease and DiabetesCardiac electrophysiology and arrhythmiasAdvanced Sensor and Energy Harvesting MaterialsParathyroid Disorders and Treatments

Les publications récentes

2026 article OpenAlex

Discovery of Piezoelectricity in Natural Birch Bark for AI-Assisted Sports Violation Monitoring

Biyao Huang, Chu Pan, X Li, J N Li et autres

The rapid advancement of wearable electronics has created an urgent demand for distributed, sustainable, and green energy sources to power various microdevices. As the conventional lithium battery is harmful to the environment, the biopiezoelectric nanogenerator is an ideal candidate to meet these …

cn, ch (code pays fourni par la source)

0 citations ACS Sustainable Chemistry & Engineering
Accès ouvert 2023 article OpenAlex

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne, Christoph Wanner et autres

BackgroundThe EMPA-KIDNEY trial showed that empagliflozin reduced the risk of the primary composite outcome of kidney disease progression or cardiovascular death in patients with chronic kidney disease mainly through slowing progression.We aimed to assess how effects of empagliflozin might differ by primary …

in, gb, de, us (code pays fourni par la source)

122 citations The Lancet Diabetes & Endocrinology
Accès ouvert 2023 article OpenAlex

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge, Christoph Wanner et autres

Background Sodium-glucose co-transporter-2 (SGLT2) inhibitors reduce progression of chronic kidney disease and the risk of cardiovascular morbidity and mortality in a wide range of patients.However, their effects on kidney disease progression in some patients with chronic kidney disease are unclear because few …

gb (code pays fourni par la source)

98 citations The Lancet Diabetes & Endocrinology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.